Medicenna Therapeutics
Why Robinhood?
You can watch MDNAF and buy or sell other stocks, ETFs, and their options commission-free!About MDNAF
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers.
MDNAF Key Statistics
Stock Snapshot
With a market cap of 25.72M, Medicenna Therapeutics(MDNAF) trades at $0.32. The stock has a price-to-earnings ratio of -2.01.
On 2026-08-18, Medicenna Therapeutics(MDNAF) stock opened at $0.32, reached a high of —, and a low of —.
The Medicenna Therapeutics(MDNAF)'s current trading volume is 0, compared to an average daily volume of 53.91K.
During the past year, Medicenna Therapeutics(MDNAF) stock moved between $0.23 at its lowest and $1.43 at its peak.
During the past year, Medicenna Therapeutics(MDNAF) stock moved between $0.23 at its lowest and $1.43 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.